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Objectives . The saccharide ultrasound contrast agent SHU 500
A was used to test the hypothesis that an intravenous, transpul-
monary contrast method can enhance color Doppler w signals In
the left atrium In a clinically useful manner
.
Rackgrosnd. Color Doppler display of mitral regurgitation
may be unreliable because of variable signal to noise ratios that
are at times poor. Tr Itional contrast agents enhance color
Doppler flow signals in the right heart chambers. This study
describes our observation of a recently developed contrast agent,
SITU 908 A, capable of pulmonary transit after peripheral venous
innjection.
Methods. Control subjects (n = 10) and patients with suspected
mitral regurgitation (n = 23) were studied by color Doppler flow
Imaging before and after 3-g intravenous doses of SITU 508 A .
Reference grading of mitral regurgitation (0 to 3) was formulated
from left ventricular an Biography. In the four-chamber view of
the left atrium, we selected for analysis the systolic frame with the
maximal retrograde jet of mitral regurgitation (aliasedlblue) and
The use of color Doppler flow imaging has facilitated the
noninvasive diagnosis of valvular disease . However, in
adults, the actual display of intracardiac flow is limited
because distant structures like the left atrium are subject to
increased absorption and scattering of ultrasound . In partic-
ular, the classification and quantitation of atrioventricular
valve regurgitation may be limited by reduced sensitivity in
Doppler interrogation at the depths encountered when the
examination is performed from the apical window (1-3) .
Enhancement of low intensity Doppler signals by contrast
agents has been demonstrated in experimental and human
studies (4-8), thus revealing information on Doppler studies
not otherwise available because of poor signal to noise ratio .
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the diastolic frame with the maximal color coding from antero-
grade pulmonary venous flow (red) for planimetry and for grading
the intensity of the color Deppler signal (0 to 5) .
Results. The score of the color Doppler signal intensity in-
creased by at2 .5 after 3 g of SHU 508 A (p < 0 .001). Flow
detection improved, as shown by the Increased jet area of mitral
regurgitation (?170% after 3 g of SHIM 508 A (3 t 3 vs . 12 ±
8 cm5, p < 0.001) and by a ia20O% increase in normal antero-
grade flow area (p < 0.001) in both the mitral regurgitation group
and the control group . After contrast enhancement, the correla-
tion between anglographic grading and the relation of jet area to
the left atrial area Increased from r = 0.79 to r = 0 .91 .
Conclusion. Contrast-mediated Increased echogenicity of the
left atria] blood pool improves the signal to noise ratio of Doppler
Images of ,.nitral regurgitation and anterograde atrial flow. The
technique is safe and simple and seems to minimize variability due
to instrument design and natomic signal attenuation .
0 Am Coll Cardiol 1993x2:521-8)
This augmentation has been limited to the tight heart (9) .
Recently, a contrast agent capable of pulmonary transmis-
sion, SIlO 5 A, has been developed (Schering AG) (10,11) .
In this study, we test the hypothesis that the intravenous
saccharide echo contrast agent, SHU 508 A, can enhance
color Doppler flow images of regurgitant and forward flow
within the left atrium . The major focus of our efforts was to
test the ability of this agent to enhance left-sided flow signals
in a clinically useful manner, namely, in the improved
evaluation of mitral regurgitation .
Methods
Study patients . The protocol for this prospective study
was submitted to and approved by the Institutional Review
Board of the Technical University, Munich, in December
1989 (established according to Food and Drug A,dminilstra-
tion guidelines) . Informed consent was obtained from ail 34
subjects
. Patients were unselected with regard to the quality
of echocardiographic and color Doppler flow images ; how-
ever, one patient had to be excluded because of complete
failure of imaging.
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Control group.
Ten patients (mean age 55 years [range 23
to 681, mean weight 81 ± 17 kg and mean height 174 9 cm)
with sinus rhythm, no murmurs and normal echocardio-
grams had left heart catheterization for the evaluation of
chest pain . Trivial mitral regurgitation by echocardiography
and Doppler study was not an exclusion criterion, nor was
obesity (n = 4) or emphysema (n = 1) .
Mitral regurgitation group
.
Twenty-three consecutive
patients had left ventricular angiograms for suspected mitral
regurgitation. The group consisted of I I men and 12 women
(mean age 61 years [range 49 to 78), mean weight 73 ± 13 kg,
mean height 169 ± 10 cm). Obesity was present in three
patients and emphysema in two . The causes for valvular
disorder were rheumatic valvular disease (n = 6), flail mitral
valve leaflet (n = 2), bacterial endocarditis (n = 2), mitral
valve prolapse (n = 3), ischemic heart disease (n = 4) .
cardiomyopathy (n 4) and hypertensive heart disease (n
2). Six patients had moderate or severe mitral stenosis, and
one patient had a bioprosthetic mitral valve. Sinus rhythm
was present in I I patients and atrial fibrillation in 12 .
Cardiac catheterization . There was no premedication
given before the procedure . Catheters were inserted through
the percutaneous femoral route . Biplane left ventricular
angiograms were performed in a 30° right anterior oblique
and a 60° left anterior oblique projection, with injection of 45
to 55 ml of iopamidol at 12 to 15 mils . The severity of mitral
regurgitation was graded as 0 = none . I = mild, 2 =
moderate and 3 = severe regurgitation, according to the
classification of Nagle et al . (12) . Interpretation was per-
formed by consensus of two observers who were unaware of
the clinical and color Doppler data of the patient .
Contrast agent . The contrast agent SHU 508 A is a
suspension of galactose microparticles (median diameter
2 on.) in water (300 mglmi). The suspension was prepared
2 min before injection by adding sterile water (13 .5 mi) to the
vial with SHU 508 A granules. Using a 20-gauge cannula,
10-ml aliquots of SHU 508 A were hand-injected into an
antecubital vein over a period of 2 s, followed by a saline
solution flush of 5 ml . A second injection of 3 g followed after
5 min or after contrast effects had completely disappeared .
Hemodynamic effects were monitored by pulse rate and
blood pressure before and during injection as well as 0.5 and
24 h later. Blood samples were analyzed for electrolytes,
urea, liver enzymes, coagulation and hematology before and
0.5 and 24 h after injection . After each injection, patients
were questioned about the presence of side effects or any
subjl.ctive complaint .
Study design . The study was designed as a two-center
study to allow the comparison of both center' data, with
blinded evaluation of the color Doppler recordings within
each center and subsequent exchange of randomly selected
tapes from a subgroup of 14 patients . Blinded reading for
interobserver variability included selecting the frame with
maximal color-coded areas in the left atrium and quantitating
these areas by planimetry
. The intercenter interobserver
variability was measured by experienced colleagues, who
independently evaluated the tapes and were unaware of
patient data from the history and clinical examinations . Data
v.ere collected using one of three ultrasound devices in
random sequence (Hewlett-Packard Sonos 1000 and Toshiba
SSH 65A and 160) (represented later in Table 3 by the letters
X, Y and Z). Blood presk are and heart rate were measured
during both the echocardiographic and angiographic studies .
Doppler examination. Ultrasound investigations were
carried out 53 days before angiography while patients were
in clinically stable condition . Medications were uninter-
rupted . Color Doppler examination was performed from the
apical views with the patient positioned in left recumbency .
Each examination was performed with the use of a 2 .5-MHz
transducer, 400-Hz filter setting, 4-kHz pulse repetition
frequency, individually optimized gain setting and the nar-
rowest sector angle K60° capable of encompassing the entire
left atrium . Machine settings were kept constant for before
and during contrast recordings. All studies were stored on
VHS videotape for off-line analysis on a Dextra 200 com-
puter system .
Measurements. Pulmonary transmission time of mi-
crobubbles was measured as the time observed from the first
appearance of color Doppler enhancement in the right atrium
to the appearance of color Doppler enhancement in the left
atrium to differentiate it from intracardiac shunts . In ,the
four- and two-chamber views, we selected the frames with
maximal jet area of mitral regurgitation and the diastolic
frames with maximal color coding from anterograde pulmo-
nary venous filling in the left atrium . The color-coded areas
were measured by planimetry . Mitral regurgitation jet area
was defined as those regions of disturbed flow in which there
were variance and aliasing . as well as the immediately
contiguous nondisturbed velocities coded in blue . Regurgi-
tation areas were also classified as early systolic (<0 .50
systole) or holosystolic . Measurements were taken from
three cardiac cycles and averaged . Cavity area was mea-
sured from the same frame as maximal flow . Areas of
undi&turbed flow and jet areas were presented as absolute
areas cm and were also expressed as a percent of the
cavity area. Color Doppler signal intensity of anterograde
flow in the left atrium was graded from 0 to 5 0 = no flow
detected, I = scarce signals . 2 = weak signals, 3 = moderate
signals, 4 = good signals, 5 = signals too strong or artifac-
tual , as previously described 4,13 .
Statistical analysis. Differences between data obtained in
individual groups in this study were assessed using non-
parametric tests. These were the Wilcoxon signed rank test
and Friedman test for paired data and the Mann-Whitney
and Kruskal-Wallis tests for unpaired data . The differences
were considered significant if p < 0.05 for two-tailed testing .
Results are presented as mean value ± SD in the text and
tables and as box plots of percertiles in the graphs . Inter-
observer variability was determined by simple linear regres-
sion analysis .
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Table l . Comparison of Left Atrial and Regurgitant Jet Areas
Before and After Color Doppler Contrast Enhancement in 23
Patients With Mitral Regurgitation and in 10 Control Subjects
"p
< 0.05 and t p < 0 .001 compared with unenhanced color Doppler study .
Values are presented as mean value ± SD or p value . 4CV = four-chamber
view; MR = mitral regurgitation
; 2CV = two-chamber view .
Results
Enhancement of flow display in the control group. There
was ne holosystolic mitral regurgitation in this group . Early
systolic regurgitation was visible before administration of
SP!J 508 A in one patient and after SHU 508 A in six
pe.. ;tents. Thus, jet area increased from 0 .1 ± 0.4 to 1 .4 ±
1 .3 cm 2 p < 0.05 Table 1 . Only 21 ± 24% of the left atrial
cross-sectional areas had diastolic color flow signals Fig. 1
before contrast injection . Color Doppler signal enhancement
in the right heart chambers was seen ~4 s after intravenous
injection. After a pulmonary transit time of 5 ± 2 s, there
was a pronounced increase in color Doppler signal intensity
in the left atrium Fig. 2 and. 3 . Diastolic color flow area
increased by 330% p < 0.001 . In this group, flow enhance-
ment was sufficient to allow delineation of atrial flow in all ;
there were no distorting artifacts . Doppler signal enhance-
ment persisted for 63 ± 37 s in the left heart chambers and
then gradually subsided without significant differences
among patient groups .
Figure 1 . Increase in color-coded diastolic anterograde flow area
expressed as a percent of left atrial area after 3 g of SHU 508 A .
Median central line In box with 75th 25th upper [lower] end of
box and 90th 10th upper [lower] short line percentile values are
shown. p < 0.01 ; p < 0.001 unenhanced color Doppler
recording versus recording after injection of SHU 508 A .
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Enhanced flow display in the mitral regurgitation group.
Pulmonary transmission time was 8 ± 3 s_ Using unenhanced
Doppler imaging, mitral regurgitation was not visualized in I
patient and was displayed in early systole in I I patients and
throughout systole in 11 . After contrast injection, the display
of regrtrgitation was changed from early to holosystolic in 6
of I I patients when 5 were now classified as having early
systolic and 17 as holosystolic regurgitation . After contrast
injection, jet area of mitral regurgitation Fig. 4 increased by
270% in the four-chamber view and by 170% in the two-
chamber view p < 0.001 Table 1 . Respectively, the
relation of jet area to atrial area increased from 15 ± 12% to
46 ± 25% in the four-chatn • .:r view and from 15 ± 13% to
36 ± 22% in the two-chamber view p < 0.001 . SHU 508 A
increased left atrial anterograde flow areas during diastole by
200% p < 0.001 i :; . 1 . In the two patients with a flail
mitral valve, the relation of eccentric jet area to left atrial
area increased from X19% to -81% after SHU 508 A . The
severity of mitral regurgitation as derived from angiography
and color Doppler flow areas of anterograde and regr •gitant
atrial flow were not significantly different between patients
with atrial fibrillation and patients in sinus rhythm . Values in
the subset of seven patients with mitral stenosis and a
bioprosthetic mitral valve were compa -^d with the mean
values of the remaining patients n = iu , with matched
degrees of regurgitation before and after SHU 508 A : Antero-
grade aad retrograde atrial flow areas did not differ signifi-
cantly between these groups .
Evaluating severity of mitrall regurgitation . By angio-
graphic grading of mitral regurgitation in the mitral regurgi-
tation group, two patients were classified as free of signifi-
cant regurgitation grade 0 and eight as having grade I ,
seven as having grade 2 and six as having severe regurgita-
tion . All patients in the control group had grade 0 regurgita-
tion . The distribution of individual jet areas as a percent of
left atrial area was compared with the reference grading for
all patients, as shown in Figure 5 . Before administration of
SHU 508 A, there was poorer discrimination of severity . The
correlation coefficient was r = 0 .79. After contrast enhance-
ment, the individual values agreed closely when compared
with the corresponding reference grade r = 0 .91
. Visual
inspection revealed an optimal separation of holosystolic jet
areas at 10% for no versus mild mitral regurgitation p <
0.02 , 40% for mild versus moderate
p < 0.01 and 70% for
moderate versus severe p < 0.002 .
Study design. Blood pressure 132/82 ± 18110 mm Hg
and heart rate 78 ± 11 beats/min during echo contrastt
studies were not significantly different from those during
cardiac catheterization 133173 ± 16/13 mm Hg, 80
10 beats/min
. There were no differences in the size and
signal intensity of the color-coded areas when those after the
first contrast injection were compared with those after the
second injection . There were no significant differences be-
tween the two centers in measurements of color Doppler
areas before and after contrast injection
. When comparing
the interobserver variability between two centers and be-
Unenhanced SHU 508 A 3 g
4CV 2CV
4CV 2CV
Left atrium
Control group
15 t 5 13 ± 5 16 ± 5
15 ± 4
p value 0 .001 0.01 0.001 0.01
MR group 22 6 19±6 24±6 22±6
Jet area
Control group 0 x 0 0 t 0 I t I" I t l
p value 0 .001 0.01 0.001
MR group 3 t 3
3 t 3 12 ± 8$ 8± 4t
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Figure 2. Original color Doppler recording in the four-chamber view
before left and after right injection of 3 g of intravenous SHU 508
A in a patient with normal anterograde left atrial LA How during
diastole. LV
-
left ventricle ; RA = right atrium ; RV = right
ventricle .
tween observers in one center, regression
coefficients and
standard errors of the mean did not differ significantly for
measurements of cavity area and color-coded area before or
after SHU 508 A Table 2 . When the three ultrasound
devices used in this study were compared, one device
demonstrated superior sensitivity for flow detection of nor-
mal atrial anterograde flow velocities before and after con-
trast injection Table 3 . However, the increase in color
Doppler flow areas after SHU 508 A was not different among
the ultrasound systems .
Blood pressure, heart rate and blood chemistry values did
not change in the course of the study apart from postural
modifications Table 4 . The injections of SHU 508 A were
well tolerated by all patients. Three patients mentioned a
brief feeling of warmth at the injection site, but there were no
adverse effects or sensation a .
Discussion
Doppler signal enhancement by contrast agents . In unen-
hanced color-coded Doppler flow imaging, the display of
intracardiac flow is fragmentary, as shown by the high
incidence of anatomically delineated areas without any flow
signal . The circulating blood reflects only a small amount of
the ultrasound energy for Doppler signal processing . A
further reduction of the signal to noise ratio may be due to
low velocity of flow, high attenuation or increased interro-
gation depth 13-15 , so that these signals cannot pass the
threshold between noise and display of flow signals in the
ultrasound device . Because the low intensity of Doppler
signals is caused by the low echogenicity of blood, it may, as
Figure 3. Signal intensity of left atrial How in the control and mitral
regurgitation groups before and after injection of SHU 509 A . The
signal strength scores are as follows
: 0 = no flow detected; 1
-
scarce signals; 2 = weak signals; 3 = moderate signals ; 4 = good
signals ; 5 = too strong signals, artifacts . Median at fine with 75th
25th
upper [lower] end of box and 90th 10th short tine percen-
tile values are shown . p < 0.001 versus unenhanced color
Doppler study .
5
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a consequence, be compensated for by increasing this
echogenicity with contrast agents. Earlier experimental and
clinical studies 4-7 demonstrated significant enhancement
of color Doppler imaging by contrast medium, leading to
increased sensitivity for flow detection and therefore in-
creased areas of color Doppler flow display . This effect
should not be mistaken for an increase in the flow velocities
under investigation because these have been shown to
remain unaltered 4,7,16,17 .
First echocardiographic experiences with intravenous
injection of the saccharide suspension SHU 508 A in dogs
10 and in healthy volunteers 11 showed it to cause
homogeneous opacification of the left side of the heart, with
the intensity depending on the dose administered . This
report is the first to quantitate its ability to enhance color
Doppler flow imaging of the left atrium in patients .
Color Doppler enhancement of anterograde flow .
Significant increases in left heart . color Doppler signal inten-
sity were shown both in control subjects and in patients
given SHU 508 A Fig. 3 . This enhancement led to in-
creased flow detection, as measured by color-coded areas
Figure 5 . Correlation of reference
	
100
grading and individual values of color
Doppler jet area as a percent of left
atrial area in 23 patients with suspected
mitral regurgitation MR and in 10
control subjects . Left, Before contrast
injection. Severity grading according
to Helmcke et al . 20 is depicted by
gray scale . The dashed line defines the
border of early systolic jet area be-
tween grades 0 and I . Right, After
contrast enhancement with 3 g of SHU
508 A. Visual inspection reveals opti-
mal severity grading, as expressed on
the right .
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Figure 4
. Original color Doppler recording in the four-chamber view
before left and after right injection of 3 g of intravenous SHU 508
A in a patient with severe mitral regurgitation during systole .
Abbreviations as in Figure 2 .
and also by the duration of mitral regurgitant jets . Because
the cardiac cavities are full of flowing blood in the living
state, flow detection more closely mirrors reality after con-
trast enhancement, when -70% of the atrium becomes
color-coded from normal anterograde flow Fig . 1 .
Improvement of flow display was demonstrated for low
flow velocities diastolic atrial flow and high flow velocities
regurgitant mitral jet Table 1 . We anticipated increased
absorption and attenuation of ultrasound by rheumatically
thickened mitral valve structures or bioprostheses . These
conditions . however, did not reduce color Doppler enhance-
ment of left atrial flow . Furthermore, attenuation from
greater ultrasound interrogation depth appeared to be com-
pensated for by Doppler signal enhancement due to the
contrast agent . These in vivo results confirm our in vitro
severe
moderate
mild
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Table 2 . htterobserver Variability Between Two Study Centers
and Within One Study Center
Two Centers One Center
n = 14 0-20
r Value SEE r Value SEE
Atrial ai ja cm2 0.95 3 .4 0.92 3.0
CD area cm
0.87 3 .3 0.95 3.0
CD area SHU cm2 0.93 3.6 0.87
3.1
CD = color-coded diastolic anterograde flow ; SHU = 3 g of SHU 509 A,
experimental studies using a similar agent that did not
traverse the pulmonary bed K .
Evaluation of mural regurgitation . There is an increased
sensitivity for detection of rcgurgitant jets after contrast
enhancement, as shown by the data of the control group .
These regurgitant jets have small area dimensions and short
duration. They represented trivial or physiologic regurgita-
tion with a low incidence before contrast injection in the
control group, probably due to attenuation from obesity . It
was found more frequently after contrast enhancement but
may be differentiated from pathologic mitral regurgitation
Fig. 5 . In patients with pathologic mitral regurgitation, the
increase in the regurgitant jet area by -a170 0 Table 1 due to
increased echogenicity was not unexpected . It is noteworthy
that eccentric jets from flail mitral valve 18 could be
enhanced similar to the more central ones, so that the
coanda effect 19 was no longer an obvious limitation to the
evaluation of severity. In addition, the holosystolic duration
of pathologic mitral regurgitation was displayed only after
contrast injection in 6 of II patients, whereas th°ir late
systolic regurgitant flow had been below the detection
threshold in unenhanced color Doppler study .
The essential point to be determined is whether contrast
enhancement is useful for the assessment of severity of
mitral regurgitation. Measuring jet area by color Doppler
study, as proposed by Helmcke et al . 20 , has been shown
in more recent studies not to be a reliable method for the
classification of mitred regurgitation because of individual
sensitivity problems due to the patient and the imaging
Table 3
. Comparison of the Ultrasound Devices Used in
This Study
p
< 0.05 versus
Z . p
<
0 .01 versus Z
. Values shown
are mean values t
SD . Diast
. = diastolic color-coded ;
LA = len atrium;
other abbreviation as in
Table 2.
Table 4 . Clinical and Laboratory Data
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p < 0
.05 versus before 5HU ; tp < 0
.01 versus before SHU ; fp < 0 .05
versus 0.5 h after SHU
. UP = blood pressure; GGT = gamma-glutamyl
transpoplidase
; sALT = serum alanine amino transFerase : sAST = serum
aspartate amino trnnsferase ; SHU =
3 g of SHU 508 A .
device 1-3,21,22 . These sensitivity problems are fairly
independent of the patient s rhythm, the type of ultrasound
machine used or the center where the study was performed .
We also demonstrate a wide scatter of the individual jet
areas in each angiographic class, with much overlap of data
between severe and mild regurgitation in the unenhanced
color Doppler images Fig. 5 . After injection of SHU 508 A,
the individual values showed improved correlation with "e
corresponding angiographic data, indicating Fetter differen-
tiation of the severity of mitral regurgitation .
These results emphasize a basic relation between regur-
gitant volume and jet area, which is influenced by many
variables, such as instrumental, patient and hemodynamic
factors Table 5
; however, the influence of most of these
variables can be minimized and clarified
. Recommendations
have been made with regard to optimal instrument settings
15 .
With regard to patient factors, echogenicity of the
blood was shown in the present study to be an important key
for visualization of Doppler information, compensating for
Before
SHU
0.5 h
After
SHU
24 h After
SHU
BP, systolic mm Hg 129 _ 21 128 t 17 123 ± 22
BP, diastolic nun Hg
78 ± 13
76 ±
I I 75 t 12
Heart rate beats/min 74 t IS 72 ± 12 74 t 14
Erythrocytes
:
~~ r 4 .5 ± 0.5 4.5 ± 0 .5 4 .7 ± 0.6
Leukocytes 103 8 .4 ± 2.2 7 .9 ± 2 .It 8.4 ± 2 .3t
Thrombocytes 103 226 ± 56 213 ± 601 231 ± 64
Neutrophils % 53 ± 18 54 ± 14 55 t 16
Lymphocytes % 34 ± 10 38 ± 8 32 t 12
Quick test % 82 t 11 82 _ 13
83 ± 14
Prolhrombin time s 41 ± 9 40 ± 9
39 t 5
Fibrinogen giliter 5.4 ± 1 .6 5 .4 _ 1 .7 5.8 ± 1 .9
Creatinine pmollliter l08
±
27 108 ± 27 117 ± 27
Urcu nitrogen mmollliter 8.5 ± 2 .5 8.2 ± 2 .5 8
.5 ± 2 .8
uric acid pmollliter 410 t 71 4111 t 71 399 ± 77
Sodium mmollliter
140 t 3 140 t 4 139 ± 7
Potassium mmoLliter 4.2 t 0 .4 4
.5 ± 0 .6 4 .5
- 0
.6
Calcium mmeliliter 0.6 ± 0 .05 0.6 ±
0 .08 0.6 ± 0 05
Chloride mmol4itcr 106 ± 8
107 ± 10 106 ± B
Phosphate mmol/Iiter 0 .4 ± 0.06 0 .4
± 0 .1 0 .5 ± 0 .1
Cholesterol mmol/liter 5 .6 ± 0.9 5 .5 ± 0.9 5 .8 ± 1
.1
Ttiiglycer de mmol/liter
2 .4 ± 1 .6 2 .4 ± 1 .9 2
.3 ± 1 .2
Total protein g/Iiter
73 ± 6 72 t 6 76 ± 6 t
Albumin %
62 ± 3 63 ± 3 62 t 3
Gamma globulin %
15 ± 3 16 t 3 15 ± 4
Alpha-amylose U4iter
83 ± 32 83 ± 32 85 ± 35
Bilirubin ptnolliter 12 ± 8 12 ± 7 15 ± 12
SALT U4iter
12 ± 6 12 ± 6 13 ± 6
sAST Miter 17 t 11 16 t 11 17 ± 12
Alkaline phosphatuse
Ui
liter
128 ± 58 130 ± 57
131 ± 61
GGT Ulliter
33 ± 38 33 ± 38
35 ± 43
X
In
= 8
Y
n = 11
Z
n = 14
Angiographic grade MR
0 to 31 1 .0 t 1 .4
1 .0 t 0 .7 1
.2 _ 1 .1
Jet area
LA %
719
7 t 6
13 t 13
LA SHU %
27
t
31
31 t 19 36 ± 28
Diast . flow area
LA %
10 t lo 9 ± 141
44 ± 25
LA SHU %
67 ± 10
49 ± 22$
83 ± 25
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Table 5. Determinants of the Basic Relation Between
Regurgitant Volume and Color Doppler Jet Area in
Mitral Regurgitation
Higher values for the variables shown modify the relation by increasing
or reducing jet area, as indicated in the heading of the respeclive column
.
the unpredictable sensitivity problems due to anatomic at-
tenuation and penetration depth . Once the sensitivity prob-
lems have been resolved by contrast enhancement . classifi-
cation of mitral regurgitation becomes simply a matter of
cardiologic evaluation of routine clinical and hemodynamic
factors .
Study limitations. This study did not evaluate whether
contrast enhancement compensates for the attenuation
caused by metallic prosthetic valves . Larger numbers of
patients will be needed or thorough evaluation of contrast
effects on color Doppler imaging in other clinical situations .
For each application, the doses and concentrations of the
contrast agent need to be standardized, as do the mode of
injection and instrument settings . Improved detection and
display of flow require new criteria for the classification of
jets, which will be the task for the near future . Experimental
studies, minimizing the problems of ultrasound absorption
and attenuation, have demonstrated a major dependence of
the spatial jet distribution on hemodynamic factors
15,21,22 . However, the patient combines both anatomic
attenuation of unknown extent and hemodynamic variables.
There are no clinical data yet as to whether the latter
influence jet size beyond the range of clinical utility once the
sensitivity problems have been resolved . Quantitative ultra-
sound techniques for the evaluation of mitral regurgitation
are needed and have been proposed 23-25 but have not yet
been generally accepted . It is likely that their value in the
clinical setting is limited by susceptibility to attenuation
problems of color Doppler flow imaging .
Clinical implications . This study has shown the impor-
tance of increasing the sensitivity of the color Doppler
system for flow detection ard improving flow display, thus
allowing observation of all ot the Doppler information avail-
able for each individual patient . The need for augmented
sensitivity for detection of mitral regurgitation has been
obvious since transesophageal color Doppler studies re-
vealed a limited display of mitral regurgitation jet area by
transthoracic echocardiography 26,27 . The technique of
contrast enhancement is a convenient means of compensa-
vo BIBRA ET AL .
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Lion, specifically when standard color Doppler study fails
because of common physical limitations, as often seen in
patients tsth obesity and emphysema. Furthermore, the
techniitie remains noninvasive and safe and is well tolerated
by p_at ents . These features make it a promising technique for
the transthoracic assessment of pulmonary venous flow
patterns 28,29 . Further investigations focusing on valvular
lesions or on the assessment of ventricular function are
necessary. This technique may be an important step toward
significant improvement of the quantification of color Dopp-
ler data in adults .
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